Our AML cohort was characterized by mutations in genes with a known pathogenic role in leukemia and the identified chimeras contributed to the disease complexity, as demonstrated by the involvement of genes such as WT1 or copy-number loss of NF1. This evidence concerns the gene NF1 and leukemia.